Health Products Stocks List



Recent Signals

Date Stock Signal Type
2021-07-27 AAME Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-27 AHCO NR7 Range Contraction
2021-07-27 AHCO NR7-2 Range Contraction
2021-07-27 AIG 20 DMA Support Bullish
2021-07-27 AIG Spinning Top Other
2021-07-27 AXS Bollinger Band Squeeze Range Contraction
2021-07-27 AXS Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-27 AXS 200 DMA Resistance Bearish
2021-07-27 BHC Bollinger Band Squeeze Range Contraction
2021-07-27 CHSCL Fell Below 20 DMA Bearish
2021-07-27 CHSCL 50 DMA Support Bullish
2021-07-27 CHSCM Stochastic Reached Overbought Strength
2021-07-27 CHSCM 20 DMA Support Bullish
2021-07-27 CHSCN New Downtrend Bearish
2021-07-27 CHSCN Lizard Bullish Bullish Day Trade Setup
2021-07-27 CHSCN Hammer Candlestick Bullish
2021-07-27 CHSCO 20 DMA Support Bullish
2021-07-27 CHSCO Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-07-27 CHSCO Narrow Range Bar Range Contraction
2021-07-27 CHSCO NR7-2 Range Contraction
2021-07-27 CHSCO NR7 Range Contraction
2021-07-27 CHSCO Fell Below 50 DMA Bearish
2021-07-27 CHSCP 180 Bearish Setup Bearish Swing Setup
2021-07-27 CHSCP Bollinger Band Squeeze Range Contraction
2021-07-27 CHSCP Fell Below 20 DMA Bearish
2021-07-27 CHSCP Fell Below 50 DMA Bearish
2021-07-27 CHWY 200 DMA Support Bullish
2021-07-27 CHWY Slingshot Bullish Bullish Swing Setup
2021-07-27 CTLT 20 DMA Support Bullish
2021-07-27 CTLT 180 Bullish Setup Bullish Swing Setup
2021-07-27 ECL Upper Bollinger Band Walk Strength
2021-07-27 ECL Slingshot Bullish Bullish Swing Setup
2021-07-27 ECL Reversal New Highs Setup Bullish Swing Setup
2021-07-27 ECL Expansion Breakout Bullish Swing Setup
2021-07-27 ECL Wide Range Bar Range Expansion
2021-07-27 ELAT 180 Bullish Setup Bullish Swing Setup
2021-07-27 EVFM Stochastic Reached Oversold Weakness
2021-07-27 EVFM NR7 Range Contraction
2021-07-27 GSK 50 DMA Resistance Bearish
2021-07-27 LLY MACD Bullish Signal Line Cross Bullish
2021-07-27 LLY NR7 Range Contraction
2021-07-27 LLY Narrow Range Bar Range Contraction
2021-07-27 LLY Upper Bollinger Band Walk Strength
2021-07-27 MBII New Downtrend Bearish
2021-07-27 MBII Hammer Candlestick Bullish
2021-07-27 MED Bollinger Band Squeeze Range Contraction
2021-07-27 MED 180 Bearish Setup Bearish Swing Setup
2021-07-27 MED Fell Below 20 DMA Bearish
2021-07-27 MRK Bollinger Band Squeeze Range Contraction
2021-07-27 MRK 200 DMA Resistance Bearish
2021-07-27 MRK 50 DMA Support Bullish
2021-07-27 MRK Crossed Above 20 DMA Bullish
2021-07-27 MTEX Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-07-27 MTEX 1,2,3 Pullback Bullish Bullish Swing Setup
2021-07-27 PETS Slingshot Bearish Bearish Swing Setup
2021-07-27 PRPH Upper Bollinger Band Walk Strength
2021-07-27 TLGT New 52 Week Closing Low Bearish
2021-07-27 TLGT Bollinger Band Squeeze Range Contraction

Health Products Stocks Recent News

Date Stock Title
Jul 27 ECL Ecolab Inc. (ECL) CEO Christophe Beck on Q2 2021 Results - Earnings Call Transcript
Jul 27 ECL Ecolab inc (ECL) Q2 2021 Earnings Call Transcript
Jul 27 AXS AXIS Capital Reports Second Quarter Net Income Available to Common Shareholders of $228 Million, or $2.67 Per Diluted Common Share
Jul 27 ECL Ecolab Inc. 2021 Q2 - Results - Earnings Call Presentation
Jul 27 GSK ‘There’s a great opportunity that we’ll have another variant’: Doctor
Jul 27 MRK ‘There’s a great opportunity that we’ll have another variant’: Doctor
Jul 27 MRK Merck Announces Fourth-Quarter 2021 Dividend
Jul 27 ECL Ecolab (ECL) Q2 Earnings & Revenues Beat Mark, Margins Rise
Jul 27 CTLT Ecolab (ECL) Q2 Earnings & Revenues Beat Mark, Margins Rise
Jul 27 MED Why Medifast (MED) is a Top Dividend Stock for Your Portfolio
Jul 27 GSK Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY
Jul 27 LLY Cassava Sciences’ Seat at the Top of the Charts Faces Gut Check
Jul 27 ECL Ecolab (ECL) Tops Q2 Earnings and Revenue Estimates
Jul 27 ECL Recap: Ecolab Q2 Earnings
Jul 27 ECL Ecolab Second Quarter Reported Diluted Continuing Operations EPS $1.08; Adjusted Diluted Continuing Operations EPS $1.22, +88%
Jul 27 CTLT PerkinElmer (PKI) Q2 Earnings and Revenues Surpass Estimates
Jul 27 MRK Merck's late-stage KEYNOTE-355 trial met endpoint of overall survival in breast cancer study
Jul 27 MRK FDA OKs Merck's Keytruda/Chemotherapy combo in triple-negative breast cancer
Jul 27 MRK Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients with Metastatic Triple-Negative Breast Cancer Whose Tumors Expressed PD-L1 (CPS ≥10)
Jul 27 MRK U.S. FDA approves Merck's Keytruda combo for early breast cancer treatment